In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

LAA occlusion: when and how

EHRA webinar

20/04/2016 18:00 20/04/2016 19:00 Europe/Paris LAA occlusion: when and how

Access event page

European Heart Rhythm Association DD/MM/YYYY
Atrial Fibrillation

Focus on

After attending this webinar, participants will know how:

  • To recall the importance of atrial fibrillation as a major cause of stroke
  • To understand that anticoagulation is indicated in the vast majority of patients with atrial fibrillation
  • To learn about the advantages and limitations of NOACs
  • To recognize LAA closure as a potential alternative to anticoagulation
  • To put the results of prospective randomized LAA closure trials and registries into perspective
  • To learn about the ongoing change in guidelines